1. Home
  2. NMT vs RCEL Comparison

NMT vs RCEL Comparison

Compare NMT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Massachusetts Quality Municipal Income Fund

NMT

Nuveen Massachusetts Quality Municipal Income Fund

HOLD

Current Price

$11.53

Market Cap

107.8M

Sector

Finance

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.42

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMT
RCEL
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.8M
102.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NMT
RCEL
Price
$11.53
$4.42
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$7.17
AVG Volume (30 Days)
19.1K
233.5K
Earning Date
01-01-0001
02-12-2026
Dividend Yield
3.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$72,401,000.00
Revenue This Year
N/A
$13.61
Revenue Next Year
N/A
$19.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
20.59
52 Week Low
$9.05
$3.22
52 Week High
$10.93
$11.25

Technical Indicators

Market Signals
Indicator
NMT
RCEL
Relative Strength Index (RSI) 56.93 73.40
Support Level $11.39 $3.24
Resistance Level $11.60 $3.94
Average True Range (ATR) 0.10 0.23
MACD 0.01 0.11
Stochastic Oscillator 81.48 87.31

Price Performance

Historical Comparison
NMT
RCEL

About NMT Nuveen Massachusetts Quality Municipal Income Fund

Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: